BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 250 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q3 2021. The put-call ratio across all filers is 0.73 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $15,324,000 | -3.9% | 101,368 | -7.4% | 0.03% | 0.0% |
| Q2 2022 | $15,950,000 | +54.2% | 109,463 | +25.5% | 0.03% | +81.2% |
| Q1 2022 | $10,342,000 | -12.4% | 87,223 | +1.8% | 0.02% | -5.9% |
| Q4 2021 | $11,808,000 | +2.7% | 85,682 | +3.5% | 0.02% | -5.6% |
| Q3 2021 | $11,495,000 | +43.0% | 82,749 | -0.0% | 0.02% | +38.5% |
| Q2 2021 | $8,036,000 | +46.5% | 82,770 | +3.1% | 0.01% | +44.4% |
| Q1 2021 | $5,487,000 | -20.2% | 80,270 | 0.0% | 0.01% | -25.0% |
| Q4 2020 | $6,880,000 | +30.4% | 80,270 | -1.1% | 0.01% | +20.0% |
| Q3 2020 | $5,275,000 | -11.2% | 81,141 | -0.1% | 0.01% | -23.1% |
| Q2 2020 | $5,939,000 | +168.1% | 81,231 | +24.8% | 0.01% | +116.7% |
| Q1 2020 | $2,215,000 | -37.8% | 65,067 | -0.6% | 0.01% | -14.3% |
| Q4 2019 | $3,562,000 | – | 65,437 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 490,422 | $12,755,876 | 13.24% |
| FNY Investment Advisers, LLC | 30 | $0 | 0.00% |